Press Release June 14, 2023 Diabetic Retinopathy Market to Observe Growth by 2032, Estimates DelveInsight | Genentech, Regeneron, Roche, Opthea Limited, Regenxbio, Kodiak Sciences, Ocuphire Pharma, Eisai Co Ltd, Apexian Pharma
Press Release June 14, 2023 Functional Dyspepsia Pipeline, Clinical Trials, and Emerging Drugs (2023) | Companies – Renexxion, Daewoong Pharmaceutical, RaQualia Pharmaceutical, and Others
Press Release June 14, 2023 Focal Segmental Glomerulosclerosis Pipeline, Clinical Trials, and Emerging Therapies (2023) | Companies – Dimerix Bioscience, Travere Therapeutics, Horizon Therapeutics, Pfizer, and Others
Press Release June 14, 2023 Merkel Cell Carcinoma Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Incyte, Kartos Therapeutics, 4SC AG, Immunomic Therapeutics, Neoimmunetech
Press Release June 14, 2023 Hepatocellular Carcinoma Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Market Forecasting by DelveInsight | AbbVie, Bayer, Novartis, Bristol-Myers Squibb, Takeda
Press Release June 14, 2023 Malignant Pleural Mesothelioma Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | AstraZeneca, Targovax, TCR2 Therapeutics, Hoffmann-La Roche, Novartis
Press Release June 14, 2023 Follicular Lymphoma Pipeline, NDA Approvals, Clinical Trials Assessment, and Emerging Drugs (2023) | Companies – Incyte Corporation, Genmab A/S, BeiGene, Merck & Co., Nordic Nanovector, and Others
Press Release June 14, 2023 Epilepsy Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Takeda, Abide therapeutics, Otsuka pharmaceutical, H. Lundbeck A/S, Spark
Press Release June 14, 2023 Fibromyalgia Pipeline, Emerging Drugs, and Clinical Trials Assessment (2023) | Companies – Virios Therapeutics, Tonix Pharmaceuticals, TRYP Therapeutics, UCB, Axsome Therapeutics, and Others
Press Release June 14, 2023 Fibrodysplasia Ossificans Progressiva Pipeline, Clinical Trials Assessment, and Emerging Drugs (2023) | Companies – Ipsen, Blueprint Medicines, Regeneron Pharma, Daiichi Sankyo, AstraZeneca, and others